(CDXC) |
| 0 (0%) 08-27 23:53 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 27 Aug 2026
Chromadex Corp (CDXC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Tue, 02 Dec 2025
Official: Hadjar to replace Tsunoda at Red Bull in 2026, Lindblad handed F1 debut - RaceFans
Thu, 24 Apr 2025
Chromadex (CDXC) Stock Price, News & Analysis - Stock Titan
Thu, 13 Mar 2025
ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - Business Wire
Tue, 23 Jul 2024
ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs) - Nasdaq
Tue, 26 Mar 2024
ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program - BioSpace
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
